Mendus AB: Mendus Publishes Preclinical Data Demonstrating Significant Anti-Tumor Synergies of Intratumoral Immune Priming with CTLA-4 Inhibition

Keep reading

Immunicum AB: Immunicum Announces Corporate Rebranding and Name Change to Mendus AB